TargetMol

AD 5

Product Code:
 
TAR-T29633
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T29633-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
AD 5 is a bioactive chemical.
CAS:
92455-12-4
Formula:
C12H13NO4
Molecular Weight:
235.239
Purity:
0.98
SMILES:
COc1ccc(CC(=O)NC(=C)C(O)=O)cc1

References

1. Nguyen TV, Crosby CM, Heller GJ, Mendel ZI, Barry ME, Barry MA. Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer. Oncolytic Virother. 2018 May 3;7:43-51. doi: 10.2147/OV.S155946. eCollection 2018. PubMed PMID: 29765912; PubMed Central PMCID: PMC5939883. 2. Zhang W, Fu J, Ehrhardt A. Novel vector construction based on alternative adenovirus types via homologous recombination. Hum Gene Ther Methods. 2018 May 14. doi: 10.1089/hgtb.2018.044. [Epub ahead of print] PubMed PMID: 29756505. 3. Jung SY, Kang KW, Lee EY, Seo DW, Kim HL, Kim H, Kwon T, Park HL, Kim H, Lee SM, Nam JH. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Vaccine. 2018 May 5. pii: S0264-410X(18)30598-X. doi: 10.1016/j.vaccine.2018.04.082. [Epub ahead of print] PubMed PMID: 29739720. 4. Li P, Feng F, Pan E, Fan X, Yang Q, Guan M, Chen L, Sun C. Scavenger receptor-mediated Ad5 entry and acLDL accumulation in monocytes/macrophages synergistically trigger innate responses against viral infection. Virology. 2018 Apr 19;519:86-98. doi: 10.1016/j.virol.2018.04.005. [Epub ahead of print] PubMed PMID: 29680370.